Frontlight ResearchEarly access
Active, not recruitingNo phase
Topical Oxygen Therapy for BRONJ
Key facts
- Who runs it
- Mansoura University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 36 people enrolled
- Started
- 1 Apr 2026
- Ended
- Sept 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Topical Blue®m application
- PRF membrane placement
- Record updated
- 24 July 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Patient Age: ≥18 years
- Patients diagnosed with BRONJ/MRONJ Stage 1-3 (AAOMS criteria).(25)
- History of antiresorptive or antiangiogenic drug use
- Patients willing to participate in the study's follow-up intervals and to provide informed consent
Who cannot take part
- Previous radiotherapy to head and neck
- Uncontrolled systemic disease (e.g., uncontrolled diabetes)
- Known allergy to Blue®m components
- Pregnancy or lactation
- Uncooperative patients
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A randomized clinical trial comparing Blue®m oral gel and autologous PRF membrane as adjuncts to surgical debridement in BRONJ/MRONJ patients.
The 2 groups in the trial
- Study Group 1Treatment being tested
18 patients diagnosed with BRONJ/MRONJ topical Blue®m oral gel were applied intraoperatively to the debrided bone surface and adjacent soft tissues before primary closure.
Treatment: Topical Blue®m application
- Study Group 2Treatment being tested
18 patients diagnosed with BRONJ/MRONJ autologous PRF membrane was prepared intraoperatively and placed over the debrided bone surface prior to flap closure.
Treatment: PRF membrane placement
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Topically Applied Oxygen-Based Therapy Versus Platelet-Rich Fibrin for Medication-Related Osteonecrosis of the Jaws: A Randomized Controlled Trial
- Record updated
- 24 July 2026